Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Brain Hemodynamic Changes Associated with Chronic Cerebrospinal Venous Insufficiency Are Not Specific to Multiple Sclerosis and Do Not Increase Its Severity.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Tocilizumab, MS, and NMOSD.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Systematic approaches to central nervous system myelin.
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
MiR-126: a novel route for natalizumab action?
mfERG_LAB: Software for processing multifocal electroretinography signals.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.

Pages